215 related articles for article (PubMed ID: 15132730)
1. A randomized trial of nicotinamide and vitamin E in children with recent onset type 1 diabetes (IMDIAB IX).
Crinò A; Schiaffini R; Manfrini S; Mesturino C; Visalli N; Beretta Anguissola G; Suraci C; Pitocco D; Spera S; Corbi S; Matteoli MC; Patera IP; Manca Bitti ML; Bizzarri C; Pozzilli P;
Eur J Endocrinol; 2004 May; 150(5):719-24. PubMed ID: 15132730
[TBL] [Abstract][Full Text] [Related]
2. Vitamin E and nicotinamide have similar effects in maintaining residual beta cell function in recent onset insulin-dependent diabetes (the IMDIAB IV study).
Pozzilli P; Visalli N; Cavallo MG; Signore A; Baroni MG; Buzzetti R; Fioriti E; Mesturino C; Fiori R; Romiti A; Giovannini C; Lucentini L; Matteoli MC; Crinò A; Teodonio C; Paci F; Amoretti R; Pisano L; Suraci C; Multari G; Suppa M; Sulli N; De Mattia G; Faldetta MR
Eur J Endocrinol; 1997 Sep; 137(3):234-9. PubMed ID: 9330586
[TBL] [Abstract][Full Text] [Related]
3. A multi-centre randomized trial of two different doses of nicotinamide in patients with recent-onset type 1 diabetes (the IMDIAB VI).
Visalli N; Cavallo MG; Signore A; Baroni MG; Buzzetti R; Fioriti E; Mesturino C; Fiori R; Lucentini L; Matteoli MC; Crinò A; Corbi S; Spera S; Teodonio C; Paci F; Amoretti R; Pisano L; Suraci C; Multari G; Sulli N; Cervoni M; De Mattia G; Faldetta MR; Boscherini B; Pozzilli P
Diabetes Metab Res Rev; 1999; 15(3):181-5. PubMed ID: 10441040
[TBL] [Abstract][Full Text] [Related]
4. A two year observational study of nicotinamide and intensive insulin therapy in patients with recent onset type 1 diabetes mellitus.
Crinó A; Schiaffini R; Ciampalini P; Suraci MC; Manfrini S; Visalli N; Matteoli MC; Patera P; Buzzetti R; Guglielmi C; Spera S; Costanza F; Fioriti E; Pitocco D; Pozzilli P;
J Pediatr Endocrinol Metab; 2005 Aug; 18(8):749-54. PubMed ID: 16200840
[TBL] [Abstract][Full Text] [Related]
5. Double blind trial of nicotinamide in recent-onset IDDM (the IMDIAB III study).
Pozzilli P; Visalli N; Signore A; Baroni MG; Buzzetti R; Cavallo MG; Boccuni ML; Fava D; Gragnoli C; Andreani D
Diabetologia; 1995 Jul; 38(7):848-52. PubMed ID: 7556988
[TBL] [Abstract][Full Text] [Related]
6. Combination of nicotinamide and steroid versus nicotinamide in recent-onset IDDM. The IMDIAB II Study.
Pozzilli P; Visalli N; Boccuni ML; Baroni MG; Buzzetti R; Fioriti E; Signore A; Cavallo MG; Andreani D; Lucentini L
Diabetes Care; 1994 Aug; 17(8):897-900. PubMed ID: 7956639
[TBL] [Abstract][Full Text] [Related]
7. The effects of calcitriol and nicotinamide on residual pancreatic beta-cell function in patients with recent-onset Type 1 diabetes (IMDIAB XI).
Pitocco D; Crinò A; Di Stasio E; Manfrini S; Guglielmi C; Spera S; Anguissola GB; Visalli N; Suraci C; Matteoli MC; Patera IP; Cavallo MG; Bizzarri C; Pozzilli P;
Diabet Med; 2006 Aug; 23(8):920-3. PubMed ID: 16911633
[TBL] [Abstract][Full Text] [Related]
8. Randomized trial comparing nicotinamide and nicotinamide plus cyclosporin in recent onset insulin-dependent diabetes (IMDIAB 1). The IMDIAB Study Group.
Pozzilli P; Visalli N; Boccuni ML; Baroni MG; Buzzetti R; Fioriti E; Signore A; Cavallo MG; Andreani D; Lucentini L
Diabet Med; 1994; 11(1):98-104. PubMed ID: 8181261
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant therapy in recent onset type 1 diabetes at diagnosis and insulin requirement after 2 years.
Pozzilli P; Visalli N; Buzzetti R; Baroni MG; Boccuni ML; Fioriti E; Signore A; Mesturino C; Valente L; Cavallo MG
Diabete Metab; 1995 Feb; 21(1):47-9. PubMed ID: 7781843
[TBL] [Abstract][Full Text] [Related]
10. No protective effect of calcitriol on beta-cell function in recent-onset type 1 diabetes: the IMDIAB XIII trial.
Bizzarri C; Pitocco D; Napoli N; Di Stasio E; Maggi D; Manfrini S; Suraci C; Cavallo MG; Cappa M; Ghirlanda G; Pozzilli P;
Diabetes Care; 2010 Sep; 33(9):1962-3. PubMed ID: 20805274
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of nicotinamide treatment in patients with recent-onset IDDM. The Nicotinamide Trialists.
Pozzilli P; Browne PD; Kolb H
Diabetes Care; 1996 Dec; 19(12):1357-63. PubMed ID: 8941464
[TBL] [Abstract][Full Text] [Related]
12. A trial of nicotinamide in newly diagnosed patients with type 1 (insulin-dependent) diabetes mellitus.
Chase HP; Butler-Simon N; Garg S; McDuffie M; Hoops SL; O'Brien D
Diabetologia; 1990 Jul; 33(7):444-6. PubMed ID: 2144835
[TBL] [Abstract][Full Text] [Related]
13. Effects of nicotinamide and intravenous insulin therapy in newly diagnosed type 1 diabetes.
Vidal J; Fernández-Balsells M; Sesmilo G; Aguilera E; Casamitjana R; Gomis R; Conget I
Diabetes Care; 2000 Mar; 23(3):360-4. PubMed ID: 10868866
[TBL] [Abstract][Full Text] [Related]
14. No effect of oral insulin on residual beta-cell function in recent-onset type I diabetes (the IMDIAB VII). IMDIAB Group.
Pozzilli P; Pitocco D; Visalli N; Cavallo MG; Buzzetti R; Crinò A; Spera S; Suraci C; Multari G; Cervoni M; Manca Bitti ML; Matteoli MC; Marietti G; Ferrazzoli F; Cassone Faldetta MR; Giordano C; Sbriglia M; Sarugeri E; Ghirlanda G
Diabetologia; 2000 Aug; 43(8):1000-4. PubMed ID: 10990077
[TBL] [Abstract][Full Text] [Related]
15. Effect of nicotinamide on newly diagnosed type 1 diabetic children.
Kamal M; Abbasy AJ; Muslemani AA; Bener A
Acta Pharmacol Sin; 2006 Jun; 27(6):724-7. PubMed ID: 16723091
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of preserved insulin secretion in children and adolescents with type 1 diabetes].
Wegner O; Wyka K; Fendler W; Zmysłowska A; Młynarski W
Pediatr Endocrinol Diabetes Metab; 2010; 16(2):67-71. PubMed ID: 20813081
[TBL] [Abstract][Full Text] [Related]
17. [Use of alpha-tocopherol acetate and nicotinamide at the onset of insulin dependent diabetes mellitus].
Dedov II; Gorelysheva VA; Romanovskaia GA; Filippov IK; Smirnova OM
Klin Med (Mosk); 1995; 73(6):40-3. PubMed ID: 8691780
[No Abstract] [Full Text] [Related]
18. Age-dependent decline of β-cell function in type 1 diabetes after diagnosis: a multi-centre longitudinal study.
Barker A; Lauria A; Schloot N; Hosszufalusi N; Ludvigsson J; Mathieu C; Mauricio D; Nordwall M; Van der Schueren B; Mandrup-Poulsen T; Scherbaum WA; Weets I; Gorus FK; Wareham N; Leslie RD; Pozzilli P
Diabetes Obes Metab; 2014 Mar; 16(3):262-7. PubMed ID: 24118704
[TBL] [Abstract][Full Text] [Related]
19. Effect of heat shock protein peptide DiaPep277 on beta-cell function in paediatric and adult patients with recent-onset diabetes mellitus type 1: two prospective, randomized, double-blind phase II trials.
Schloot NC; Meierhoff G; Lengyel C; Vándorfi G; Takács J; Pánczél P; Barkai L; Madácsy L; Oroszlán T; Kovács P; Sütö G; Battelino T; Hosszufalusi N; Jermendy G
Diabetes Metab Res Rev; 2007 May; 23(4):276-85. PubMed ID: 17103487
[TBL] [Abstract][Full Text] [Related]
20. Treatment of new-onset type 1 diabetes with peptide DiaPep277 is safe and associated with preserved beta-cell function: extension of a randomized, double-blind, phase II trial.
Raz I; Avron A; Tamir M; Metzger M; Symer L; Eldor R; Cohen IR; Elias D
Diabetes Metab Res Rev; 2007 May; 23(4):292-8. PubMed ID: 17124720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
